Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2009 2
2010 2
2011 3
2012 1
2013 2
2014 1
2015 2
2016 2
2017 1
2018 2
2019 2
2020 2
2021 1
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases.
Perdiguero B, Pérez P, Marcos-Villar L, Albericio G, Astorgano D, Álvarez E, Sin L, Gómez CE, García-Arriaza J, Esteban M. Perdiguero B, et al. Among authors: marcos villar l. J Mol Biol. 2023 Aug 1;435(15):168173. doi: 10.1016/j.jmb.2023.168173. Epub 2023 Jun 8. J Mol Biol. 2023. PMID: 37301278 Free PMC article. Review.
Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidate.
Perdiguero B, Marcos-Villar L, López-Bravo M, Sánchez-Cordón PJ, Zamora C, Valverde JR, Sorzano CÓS, Sin L, Álvarez E, Ramos M, Del Val M, Esteban M, Gómez CE. Perdiguero B, et al. Among authors: marcos villar l. Front Immunol. 2023 Jun 19;14:1160065. doi: 10.3389/fimmu.2023.1160065. eCollection 2023. Front Immunol. 2023. PMID: 37404819 Free PMC article.
An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses.
Falqui M, Perdiguero B, Coloma R, Albert M, Marcos-Villar L, McGrail JP, Sorzano CÓS, Esteban M, Gómez CE, Guerra S. Falqui M, et al. Among authors: marcos villar l. Front Cell Infect Microbiol. 2023 May 29;13:1187193. doi: 10.3389/fcimb.2023.1187193. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37313341 Free PMC article.
Control of virus infection by tumour suppressors.
Muñoz-Fontela C, García MA, Collado M, Marcos-Villar L, Gallego P, Esteban M, Rivas C. Muñoz-Fontela C, et al. Among authors: marcos villar l. Carcinogenesis. 2007 Jun;28(6):1140-4. doi: 10.1093/carcin/bgm048. Epub 2007 Mar 7. Carcinogenesis. 2007. PMID: 17347139 Review.
SUMOylation of p53 mediates interferon activities.
Marcos-Villar L, Pérez-Girón JV, Vilas JM, Soto A, de la Cruz-Hererra CF, Lang V, Collado M, Vidal A, Rodríguez MS, Muñoz-Fontela C, Rivas C. Marcos-Villar L, et al. Cell Cycle. 2013 Sep 1;12(17):2809-16. doi: 10.4161/cc.25868. Epub 2013 Aug 5. Cell Cycle. 2013. PMID: 23966171 Free PMC article.
KSHV latent protein LANA2 inhibits sumo2 modification of p53.
Laura MV, de la Cruz-Herrera CF, Ferreirós A, Baz-Martínez M, Lang V, Vidal A, Muñoz-Fontela C, Rodríguez MS, Collado M, Rivas C. Laura MV, et al. Cell Cycle. 2015;14(2):277-82. doi: 10.4161/15384101.2014.980657. Cell Cycle. 2015. PMID: 25607652 Free PMC article.
Acetylation is indispensable for p53 antiviral activity.
Muñoz-Fontela C, González D, Marcos-Villar L, Campagna M, Gallego P, González-Santamaría J, Herranz D, Gu W, Serrano M, Aaronson SA, Rivas C. Muñoz-Fontela C, et al. Among authors: marcos villar l. Cell Cycle. 2011 Nov 1;10(21):3701-5. doi: 10.4161/cc.10.21.17899. Epub 2011 Nov 1. Cell Cycle. 2011. PMID: 22033337 Free PMC article.
27 results